BioVie prices $6.0M registered direct offering at $2.25/share; issues warrants at $2.12

BIOVIE INC.

Gross proceeds of ~$6,000,750 from 2,667,000 shares of common stock at $2.25 per share.
Concurrent private placement of warrants to purchase 2,667,000 shares at $2.12/share, exercisable after 6 months, expiring 5 years later.
Closing expected on October 24, 2024; ThinkEquity acting as sole placement agent.
Net proceeds to be used for working capital and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.